Navigation Links
WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year
Date:11/30/2009

SHANGHAI, Nov. 30 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company with operations in China and the United States, announced that it had been selected to the Deloitte Technology Fast 50 China 2009 list for the fifth consecutive year. The list recognizes the 50 fastest-growing companies in China's technology, media, and telecommunications industries based on revenue growth rates over the previous three years. WuXi PharmaTech is one of only two companies to have won this award for five consecutive years.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

"This recognition is a credit to the dedication and hard work of our employees and the high quality of service they deliver," said Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. "Through expansion of our capabilities and capacity, both in China and the United States, we are building a broad and fully integrated platform of pharmaceutical R&D services for our customers. We are confident that our continued investment in this platform will generate strong future revenue growth."

    For more information, please contact:

    WuXi PharmaTech (Cayman) Inc.

     Ronald Aldridge (for investors)
     Director of Investor Relations
     Tel:   +1-201-585-2048
     Email: ir@wuxiapptec.com

     Stephanie Liu (for the media)
     WuXi PharmaTech (Cayman) Inc.
     Tel:   +86-21-5046-4362
     Email: pr@wuxiapptec.com

SOURCE WuXi PharmaTech (Cayman) Inc.


'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Quest PharmaTech Acquires Late-Stage Immunotherapeutic Antibody Pipeline
2. WuXi PharmaTech Announces Second-Quarter 2009 Results
3. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting
4. WuXi PharmaTech Schedules Second-Quarter 2009 Earnings Release
5. WuXi PharmaTech Receives Award from BASF
6. WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
7. WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
8. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
9. WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference
10. WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release
11. Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016  Spectra BioPharma Selling Solutions (Spectra) is ... biopharma companies the experience, expertise, operational delivery and ... sales teams. Created in concert with industry leading ... strategic and tactical needs of its clients by ... both personal and non-personal promotion. ...
(Date:2/11/2016)... York, NY (PRWEB) , ... ... ... (BPI), a business-to-business publication dedicated to delivering cutting-edge information focused on the ... Healthcare Life Sciences to become a premier sponsor of the 2016 BioProcess ...
(Date:2/11/2016)... , February 11, 2016 ... Corporation ("PositiveID" or "Company") (OTCQB: PSID), a life ... today that its Thermomedics subsidiary, which markets the ... its growth plan in January 2016, including entering ... increasing sequential monthly sales growth, and establishing several ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... 150 years, continues today to pursue the highest level of accuracy and quality ... the AR9 Refractometer and the AR5 Refractometer. Accurate, reliable and tough enough ...
Breaking Biology Technology:
(Date:2/1/2016)... -- Rising sales of consumer electronics coupled ... gesture control market size through ... electronics coupled with new technological advancements to drive global ... through 2020   --> Rising ... to drive global touchfree intuitive gesture control market ...
(Date:1/28/2016)... 28, 2016 Synaptics (NASDAQ: SYNA ), a leading ... second quarter ended December 31, 2015. --> ... fiscal 2016 increased 2 percent compared to the comparable quarter last ... fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... for the first quarter of fiscal 2016 grew 9 percent over ...
(Date:1/25/2016)... 25, 2016  Glencoe Software, the world-leading supplier of ... industries, will provide the data management solution OMERO Plus ... Photo - ... Phenotypic analysis measures the characteristics and ... comparisons between states such as health and disease, the ...
Breaking Biology News(10 mins):